Dermata Therapeutics (DRMA) Stock Chart & Stock Price History $0.70 -0.03 (-4.01%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.72 +0.02 (+3.42%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.77%, with a year-to-date return of -48.07%. In the past month, the stock has decreased 0.93%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.70 with a market cap of $4.47 million and volume of 275,767 shares. Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.27%1 Month Performance-0.93%3 Month Performance-3.84%Year-To-Date Performance-48.07%1 Year Performance-64.77% DRMA Stock Chart for Thursday, July, 17, 2025 DRMA Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/16/2025$0.73$0.70-4.01%$0.74$0.69275,767 shs$4.47 million07/15/2025$0.73$0.73+0.18%$0.78$0.70169,181 shs$4.66 million07/14/2025$0.71$0.73+2.68%$0.80$0.69268,133 shs$4.65 million07/11/2025$0.72$0.71-1.35%$0.78$0.69168,566 shs$4.53 million07/10/2025$0.65$0.72+10.76%$0.72$0.6670,673 shs$4.59 million07/09/2025$0.63$0.65+3.14%$0.71$0.6379,915 shs$4.15 million07/08/2025$0.70$0.63-9.35%$0.68$0.61705,708 shs$4.02 million07/07/2025$0.67$0.70+4.35%$0.74$0.64156,415 shs$4.24 million07/04/2025$0.67$0.67$0.70$0.6542,072 shs$4.25 million07/03/2025$0.67$0.67-0.15%$0.70$0.6542,072 shs$4.25 million Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/02/2025$0.64$0.67+4.12%$0.69$0.6488,484 shs$4.26 million07/01/2025$0.59$0.64+9.50%$0.65$0.5968,315 shs$4.09 million06/30/2025$0.60$0.59-3.21%$0.63$0.5950,410 shs$3.73 million06/27/2025$0.59$0.60+3.14%$0.61$0.5981,564 shs$3.86 million06/26/2025$0.63$0.59-6.33%$0.63$0.57103,125 shs$3.74 million06/25/2025$0.63$0.63-0.70%$0.63$0.60110,893 shs$3.99 million06/24/2025$0.63$0.63-0.32%$0.65$0.61139,965 shs$4.02 million06/23/2025$0.68$0.63-6.48%$0.68$0.6361,676 shs$4.03 million06/20/2025$0.69$0.68-2.64%$0.68$0.66113,374 shs$4.31 million06/19/2025$0.69$0.69$0.72$0.65132,909 shs$4.43 million06/18/2025$0.71$0.69-1.91%$0.72$0.65132,909 shs$4.43 million06/17/2025$0.70$0.71+1.09%$0.73$0.6847,329 shs$4.51 million06/16/2025$0.71$0.70-1.73%$0.71$0.6950,049 shs$4.47 million Related Companies RVPH Stock Chart HOTH Stock Chart CTXR Stock Chart CLDI Stock Chart DRRX Stock Chart CARM Stock Chart MRKR Stock Chart PRPH Stock Chart RLYB Stock Chart CASI Stock Chart Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
